CAS 3413-72-7: 5-(3-Methyltriazen-1-yl)imidazole-4-carboxamide
Formula:C5H8N6O
InChI:InChI=1S/C5H8N6O/c1-7-11-10-5-3(4(6)12)8-2-9-5/h2H,1H3,(H2,6,12)(H,7,10)(H,8,9)
InChI key:InChIKey=MVBPAIHFZZKRGD-UHFFFAOYSA-N
SMILES:C(N)(=O)C1=C(N=NNC)N=CN1
Synonyms:- Imidazole-4(or 5)-carboxamide, 5(or 4)-(3-methyl-1-triazeno)-
- 1H-Imidazole-4-carboxamide, 5-(3-methyl-1-triazenyl)-
- 5-[2-(Methylimino)hydrazinyl]-1H-imidazole-4-carboxamide
- 1H-Imidazole-4-carboxamide, 5-[2-(methylimino)hydrazinyl]-
- Imidazole-4-carboxamide, 5-(3-methyl-1-triazeno)-
- See more synonyms
Sort by
Found 8 products.
MTIC
CAS:MTIC has anticancer and antitumor activity and can be used to study melanoma.Formula:C5H8N6OPurity:99.51%Color and Shape:SolidMolecular weight:168.16Monomethyl triazeno imidazole carboxamide
CAS:Monomethyl triazeno imidazole carboxamide (MTIC) is a drug that is used to treat cancer. It has been shown to inhibit the proliferation of tumor cells and induce apoptosis by inhibiting the expression of proteins, such as Bcl-2, which are involved in regulating mitochondrial membrane potential. MTIC has also been shown to inhibit protein synthesis and cell signaling pathways, such as the PI3K/Akt pathway. The use of MTIC for diagnosis purposes can be achieved using electrochemical impedance spectroscopy. A concentration-time curve can be obtained by incubating a biological sample with MTIC and measuring cell response using an impedance spectrophotometer. The clinical properties of MTIC include its ability to be administered orally or intravenously, have low toxicity, and inhibit the growth of tumor cells in vivo and in vitro.Formula:C5H8N6OPurity:(¹H-Nmr) Min. 95 Area-%Color and Shape:White PowderMolecular weight:168.16 g/molMTIC
CAS:Applications A metabolite of Temozolomide, an antineoplastic.Formula:C5H8N6OColor and Shape:Off-WhiteMolecular weight:168.16
